LC3-mediated fibronectin mRNA translation induces fibrosarcoma growth by increasing connective tissue growth factor

Journal of Cell Science

Volumn 122, Issue 9, 2009, Pages 1441-1451

  Ying, Lihua ^a   Lau, Agatha ^b   Alvira, Cristina M ^a   West, Robert ^a   Cann, Gordon M ^a   Zhou, Bin ^b,c   Kinnear, Caroline ^b   Jan, Eric ^a   Sarnow, Peter ^a   Van de Rijn, Matt ^a   Rabinovitch, Marlene ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Connective tissue growth factor; Fibronectin; LC3; Microtubule associated protein; mRNA translation; Tumor invasiveness

Indexed keywords

ARGININE; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTIN; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN 1; MUTANT PROTEIN; PROTEIN LC3; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; URIDINE;

ARTICLE; CANCER INVASION; CELL ADHESION; CELL CULTURE; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; FIBROSARCOMA; GENE EXPRESSION PROFILING; GENETIC DIFFERENCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIGHT CHAIN; MICROARRAY ANALYSIS; POLYSOME; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; RNA ANALYSIS; RNA BINDING; RNA TRANSLATION; SCID MOUSE; SKIN CARCINOGENESIS; SOFT TISSUE TUMOR; TUMOR GROWTH; WILD TYPE;

ANIMALS; CELL ADHESION; CELL LINE; CELL PROLIFERATION; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTINS; FIBROSARCOMA; GENE EXPRESSION PROFILING; HUMANS; MICE; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYRIBOSOMES; PROTEIN BIOSYNTHESIS; RATS;

MUS;

EID: 67650550211     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.025957     Document Type: Article

References (60)

1. Aguirre-Ghiso, J. A., Estrada, Y., Liu, D. and Ossowski, L. (2003). ERK(MAPK) activity as a determinant of tumor growth and dormancy; Regulation by p38(SAPK). Cancer Res. 63, 1684-1695.
2. Aikawa, T., Gunn, J., Spong, S. M., Klaus, S. J. and Korc, M. (2006). Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer. Mol. Cancer Ther. 5, 1108-1116.
3. Blom, I. E., van Dijk, A. J., Wieten, L., Duran, K., Ito, Y., Kleij, L., deNichilo, M., Rabelink, T. J., Weening, J. J., Aten, J. et al. (2001). In vitro evidence for differential involvement of CTGF, TGFbeta, and PDGF-BB in mesangial response to injury. Nephrol. Dial. Transplant. 16, 1139-1148.
4. Boudreau, N., Turley, E. and Rabinovitch, M. (1991). Fibronectin, hyaluronan, and a hyaluronan binding protein contribute to increased ductus arteriosus smooth muscle cell migration. Dev. Biol. 143 235-247.
5. Cann, G., Guignabert, C., Ying, L., Deshpande, N., Bekker, J., Wang, L., Zhou, B. and Rabinovitch, M. (2008). Developmental expression of LC3α and β: Absence of fibronectin or autophagy phenotype in LC3β knockout mice. Dev. Dyn. 237, 187-195.
6. Caput, D., Beutler, B., Hartog, K., Thayer, R., Brown-Shimer, S. and Cerami, A. (1986). Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA 83, 1670-1674.
7. Chen, C. C., Chen, N. and Lau, L. F. (2001). The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts. J. Biol. Chem. 276 10443-10452.
8. Clausell, N., Molossi, S. and Rabinovitch, M. (1993). Increased interleukin-1 beta and fibronectin expression are early features of the development of the postcardiac transplant coronary arteriopathy in piglets. Am. J. Pathol. 142, 1772-1786.
9. Cooker, L., Peterson, D., Rambow, J., Riser, M., Riser, R., Najmabadi, F., Brigstock, D. and Riser, B. (2007). TNF-alpha, but not IFN-gamma regulates CCN2 (CTGF), collagen type I, and proliferation in mesangial cells: Possible roles in the progression of renal fibrosis. Am. J. Physiol. Renal Physiol. 293, F157-F165.
10. Croci, S., Lianduzzi, L., Astoolfi, A., Nicoletti, G., Rosalen, A., Sartori, F., Follo, M. Y., Oliver, N., De Giovanni, C., Nanni, P. et al. (2004). Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and pyogenic differentiation of human rhabdomyosarcoma cells. Cancer Res. 64, 1730-1736.
11. Dayton, E. T., Powell, D. M. and Dayton, A. I. (1989). Functional analysis of CAR, the target sequence for the Rev protein of HIV-1. Science 246, 1625-1629.
12. Dean, D. C., Newby, R. E. and Bourgeois, S. (1988) Regulation of fibronectin biosynthesis by dexamethasone, transforming growth factor beta, and CAMP in human cell lines. J. Cell Biol. 106, 2159-2170.
13. Frazier, K., Williams, S., Kothapalla, D., Klapper, H. and Grotendorst, G. R. (1996). Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J. Invest Dermatol. 107, 404-411.
14. Gao, R. and Brigstock, D. R. (2006). A novel integin-alpho5beta1 binding domain in module 4 of connective tissue growth factor (CCN2/ CTGF) promotes adhesion and migration of activated pancreatic stellate cells. Gut 55, 856-862.
15. Hammarback, J. A., Obar, R. A., Hughes, S. M. and Vallee, R. B. (1991). MAP1B is encoded as a polyprotein that is processed to form a complex N-terminal microtubule-binding domain. Neuron 7, 129-139.
16. Hynes, R. O. and Lander, A. D. (1992). Contact and adhesive specificities in the associations, migrations, and targeting of cells and axons. Cell 68, 303-322.
17. Ishida, K., Hiral, G., Murakami, K., Teruya, T. Simizu, S., Sodooka, M. and Osada, H. (2004). Structure-based design of a selective heparanase inhibitor as an antimetastatic agent. Mol. Cancer Ther. 3, 1069-1077.
18. Iwai, S., Pritchard, C., Mann, D. A., Kara, J. and Gait, M. J. (1992). Recognition of the high affinity binding site in rev-response element RNA by the human immunodeficiency virus type-1 rev protein. Nucleic Acids Res. 20, 6465-6472.
19. Jedsadayanmata, A., Chen, C. C., Kireeva, M. L., Lau, L. F. and Lam, S. C. (1999). Activation-dependent adhesion of human platelets to Cyr61 and Fisp12/mouse connective tissue growth factor is mediated through integrin alpha(IIb)beta3). J. Biol. Chem. 274, 24321-24327.
20. Johannes, G., Carter, M. S., Eisen, M. B, Brown, P. O. and Sarnow, P. (1999). Identification of eukaryotic; mRNAs that are translated at reduced cap binding complex eIF4F concentrations using a cDNA microarray. Proc. Natl. Acad. Sci. USA 96, 13118-13123.
21. Jones, P. L., Cowan, K. N. and Rabinovitch, M. (1997). Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease. Am. J. Pathol. 150, 1349-1360.
22. Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y. and Yoshimori, T. (2000). LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19, 5720-5728.
23. Kabeya, Y., Mizushima, N., Yamamoto, A., Oshitani-Okamoto, S., Ohsumi Y. and Yoshimori, T. (2004). LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J. Cell Sci. 117, 2805-2812.
24. Koliopanos, A., Friess, H, di Mola, F. F., Tang, W. H., Kubulus, D., Brigstock, D., Zimmermann, A. and Buehler, M. W. (2002). Connective tissue growth factor gene expression alters tumor progression in esophageal cancer. World J. Surg. 26, 420-427.
25. Kruys, V., Wathelet, M., Poupart, P., Contreras, R., Fiers, W., Content, J. and Huez, G. (1987). The 3′ untranslated region of the human interferon-beta mRNA has an inhibitory effect on translation. Proc. Natl. Acad. Sci. USA 34, 6030-6034.
26. Krays, V., Marinx, O., Shaw, G., Deschamps, J. and Huez, G. (1989). Translational blockade imposed by cytokine-derived UA-rich sequences. Science 245, 852-855.
27. Kubo, M., Kikuchi K., Nashiro, K., Kakinuma, T., Hayashi, N., Nanko, H. and Tamaki K. (1998). Expression of fibrogenic cytokines in desmoplastic malignant melanoma. Br. J. Dermatol. 139, 192-197.
28. Lewis, T., Gueydan, C., Huez, G., Tontine, J. J. and Kruys, V. (1998). Mapping of a minimal AU-rich sequence required for lipopolysaccharide-induced binding of a 55-kDa protein on tumor necrosis factor-alpha mRNA. J. Biol. Chem. 273, 13781-13786.
29. Lymn, J. S., Patel, M. K., Clunn, G. F., Rao, S. J., Gallagher, K. L. and Hughes, A. D. (2002). Thrombospondin-I differentially induces chemotaxis and DNA synthesis of human venous smooth muscle cells at the receptor-binding level. J. Cell Sci. 115, 4353-4360.
30. Malim, M. H., Himber, J, Le S. Y., Malzel, J. V. and Cullen, B. R. (1989). The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338, 254-257.
31. Mann, S. S. and Hammarback, J. A. (1994). Molecular characterization of light chain 3. A microtubule binding subunit of MAP1A and MAP1B. J. Biol. Chem. 269, 11492-11497.
32. Mason, C. A., Bigras, J. L., O'Blenes, S. B, Zhou, B., McIntyre, B., Nakamura, N., Kaneda, Y. and Rabinovitch, M. (1999a). Gene transfer in utero biologically engineers a patent ductus arteriosus in lambs by arresting fibronectin-dependent neointimal formation. Nat Med. 5, 176-182.
33. Mason, C. A., Chang, P., Fallery, C. and Rabinovitch, M. (1999b). Nitric oxide mediates LC-3-dependent regulation of fibronectin in ductus arteriosus intimal cushion formation. FASEB J 13, 1423-1434.
34. Moritani, N. H, Kubota, S., Nishida, T., Kawaki, H. Kondo, S., Sugahara, T. and Takigawa, M. (2003). Suppressive effect of overexpressed connectivc tissue growth factor on tumor cell growth in a human oral squamous cell carcinoma-derived cell line. Cancer Lett. 192, 205-214.
35. O'Blenes, C. A., Kinnear, C. and Rabinovitch, M. (2001). Tumor necrosis factor-alpha induces fibronectin synthesis in coronary artery smooth muscle cells by a nitric oxide-dependent posttranscriptional mechanism. Circ. Res. 89, 26-32.
36. Pan, L. H., Beppu, T., Kurose, A., Yamauchi, K., Sugawara, A., Suzuki, M., Ogawa, A. and Sawai, T. (2002). Neoplastic cells and proliferating endothelial cells express connective tissue growth factor (CTGF) in glioblastoma. Neurol. Res. 24, 677-683.
37. Perou, C. M., Sorlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A. et al. (2000). Molecular portraits of human breast tumours. Nature 406, 747-752.
38. Planque, N. and Perbal, B. (2003). A structural approach to the role of CCN (CYR61/CTGF/NOV) proteins in tumourigenesis. Cancer Cell Int. 3, 15.
39. Salomon, R. N., Hughes, C. C., Schoen, F. J., Payne, D. D., Pober, J. S. and Libby, P. (1991). Human coronary transplantation-associated arteriosclerosis: Evidence for a chronic immune reaction to activated graft endothelial cells. Am. J. Pathol. 138, 791-798.
40. Seidenbecher, C. I., Landwehr, M., Smalla, K. H., Kreutz, M., Dieterich, D. C., Zuschratter, W., Reissner, C., Hammarback, J. A., Backers, T. M., Gundelfinger, E. D. et al. (2004). Caldendrin but not calmodulin binds to light chain 3 of MAP1A/B: An association with the microtubule cytoskeleton highlighting exclusive binding partners for neuronal Ca(2+)-sensor proteins. J. Mol. Biol. 336, 957-970.
41. Shakunaga, T., Ozaki, T., Ohara, N., Asaumi, K., Doi, T., Nishida, K., Kawai, A., Nakanishi, T., Takigawa, M. and Inoue, H. (2000). Expression of connective tissue growth factor in cartilaginous tumors. Cancer 89, 1466-1473.
42. Shaw, G. and Kamen, R. (1986). A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46, 659-667.
43. Shimo, T., Kubota, S., Kondo, S., Nakanishi, T., Sasaki, A., Mese, H., Matsumura, T. and Takigawa, M. (2001). Connective tissue growth factor as a major angiogenic agent that is induced by hypoxia in a human breast cancer cell line. Cancer Lett. 174, 37-64.
44. Takigawa, M., Nakanishi, T., Kubota, S. and Nishida, T. (2003). Role of CTGF/HCS24/ecogenin in skeletal growth control. J. Cell Physiol. 194, 256-266.
45. Treisman, R. (1985). Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5′ element and c-fos 3′ sequences. Cell 42, 889-902.
46. Troussard, A. A., Tan, C., Yoganathan, T. N. and Dedhar, S. (1999). Cell-extracellular matrix interactions stimulate die AP-1 transcription factor in an integrin-linked kinase-and glycogen synthase kinase 3-dependent manner. Mol. Cell Biol. 19, 7420-7427.
47. Troussard, A. A., Costello, P., Yoganathan, T. N., Kumagai, S., Ruskelley, C. D. and Dedhar, S. (2000). The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 (MMP-9). Oncogene 19, 5444-5452.
48. Tusher, V. G., Tibshirani, R. and Chu, G. (2001). Significance analysis of microarrys applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98, 5116-5121.
49. Vorwerk, P., Wex, H., Hohmann, B., Mohnike, K., Schmidt, U. and Mittler, U. (2002). Expression of components of the IGF signalling system in childhood acute lymphoblastic leukaemia. Mol. Pathol. 55, 40-45.
50. Wei, Y., Tang, C. H., Kim, Y., Robillard, L., Zhang, F., Kugler, M. C. and Chapman, H. A. (2007). Urokinase rcceptor are required for alpha 5 beta 1 integrin-mediated signaling in tumor cells. J. Biol. Chem. 282, 3929-3939.
51. Weiss, M. A. and Narayana, N. (1998). RNA recognition by arginine-rich peptide motifs. Biopolymers 48, 167-180.
52. Wenger, C., Ellenrieder, V., Alber, B., Lacher, U., Menke, A., Hameister, H., Wilda, M., Iwamura, T., Beger, H. G., Adler, G. et al. (1999). Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells. Oncogene 18, 1073-1080.
53. West, R. B. and van de Rijn, M. (2006). The role of microarray technologies in the study of soft tissue tumours. Histopathology 48, 22-31.
54. Weston, B. S., Wahab, N. A. and Mason, R. M. (2003). CTGF mediates TGF-beta-induced fibronectin matrix deposition by upregulating active alpha5beta1 integrin in human mesangial cells. J. Am. Soc. Nephrol. 14, 601-610.
55. Xie, D., Nakachi, K., Wang, H., Elashoff, R. and Koeffler, H. P. (2001). Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res. 61, 8917-8923.
56. Xie, D., Yin, D., Wang, H. J., Liu, G. T., Elashoff, R., Black, K. and Koeffler, H. P. (2004). Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas. Clin. Cancer Res. 10, 2072-2081.
57. Zaman, M. H., Trapanie, L. M., Sieminski, A. L., Mackellar, D., Gong, H., Kamm, R. D., Wells, A., Lauffenburger, D. A. and Matsudaira, P. (2006). Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. Proc. Natl. Acad. Sci. USA 103, 10889-10894.
58. Zeng, Z. J., Yang, L. Y., Ding, X. and Wang, W. (2004). Expressions of cysteine-rich61, connective tissue growth factor and Nov genes in hepatocellular carcinoma and their clinical significance. World J. Gastroenterol. 10, 3414-3418.
59. Zhou, B. and Rabinovitch, M. (1998). Microtubule involvement in translational regulation of fibronectin expression by light chain 3 of microtubule-associated protein 1 in vascular smooth muscle cells. Circ. Res. 83, 481-489.
60. Zhou, B., Boudreau, N., Coulber, C., Hammarback, J. and Rabinovitch, M. (1997). Microtubule-associated protein 1 light chain 3 is a fibronectin mRNA-binding protein linked to mRNA translation in lamb vascular smooth muscle cells. J. Clin. Invest. 100, 3070-3082.